×
S&P 500   3,844.80 (-1.42%)
DOW   31,146.85 (-0.93%)
QQQ   285.55 (-2.36%)
AAPL   138.83 (-2.00%)
MSFT   258.84 (-2.28%)
META   163.05 (-3.80%)
GOOGL   2,246.42 (-3.03%)
AMZN   107.90 (-4.70%)
TSLA   703.20 (-4.30%)
NVDA   161.16 (-4.46%)
NIO   22.33 (-2.70%)
BABA   117.03 (-1.43%)
AMD   81.07 (-5.91%)
MU   58.77 (-0.02%)
CGC   3.59 (-5.28%)
T   20.68 (-0.48%)
GE   65.74 (-1.45%)
F   11.92 (-1.00%)
DIS   96.88 (+0.28%)
AMC   13.63 (-3.54%)
PFE   50.58 (-2.51%)
PYPL   72.42 (-4.64%)
NFLX   181.63 (-3.97%)
S&P 500   3,844.80 (-1.42%)
DOW   31,146.85 (-0.93%)
QQQ   285.55 (-2.36%)
AAPL   138.83 (-2.00%)
MSFT   258.84 (-2.28%)
META   163.05 (-3.80%)
GOOGL   2,246.42 (-3.03%)
AMZN   107.90 (-4.70%)
TSLA   703.20 (-4.30%)
NVDA   161.16 (-4.46%)
NIO   22.33 (-2.70%)
BABA   117.03 (-1.43%)
AMD   81.07 (-5.91%)
MU   58.77 (-0.02%)
CGC   3.59 (-5.28%)
T   20.68 (-0.48%)
GE   65.74 (-1.45%)
F   11.92 (-1.00%)
DIS   96.88 (+0.28%)
AMC   13.63 (-3.54%)
PFE   50.58 (-2.51%)
PYPL   72.42 (-4.64%)
NFLX   181.63 (-3.97%)
S&P 500   3,844.80 (-1.42%)
DOW   31,146.85 (-0.93%)
QQQ   285.55 (-2.36%)
AAPL   138.83 (-2.00%)
MSFT   258.84 (-2.28%)
META   163.05 (-3.80%)
GOOGL   2,246.42 (-3.03%)
AMZN   107.90 (-4.70%)
TSLA   703.20 (-4.30%)
NVDA   161.16 (-4.46%)
NIO   22.33 (-2.70%)
BABA   117.03 (-1.43%)
AMD   81.07 (-5.91%)
MU   58.77 (-0.02%)
CGC   3.59 (-5.28%)
T   20.68 (-0.48%)
GE   65.74 (-1.45%)
F   11.92 (-1.00%)
DIS   96.88 (+0.28%)
AMC   13.63 (-3.54%)
PFE   50.58 (-2.51%)
PYPL   72.42 (-4.64%)
NFLX   181.63 (-3.97%)
S&P 500   3,844.80 (-1.42%)
DOW   31,146.85 (-0.93%)
QQQ   285.55 (-2.36%)
AAPL   138.83 (-2.00%)
MSFT   258.84 (-2.28%)
META   163.05 (-3.80%)
GOOGL   2,246.42 (-3.03%)
AMZN   107.90 (-4.70%)
TSLA   703.20 (-4.30%)
NVDA   161.16 (-4.46%)
NIO   22.33 (-2.70%)
BABA   117.03 (-1.43%)
AMD   81.07 (-5.91%)
MU   58.77 (-0.02%)
CGC   3.59 (-5.28%)
T   20.68 (-0.48%)
GE   65.74 (-1.45%)
F   11.92 (-1.00%)
DIS   96.88 (+0.28%)
AMC   13.63 (-3.54%)
PFE   50.58 (-2.51%)
PYPL   72.42 (-4.64%)
NFLX   181.63 (-3.97%)
OTCMKTS:SEOVF

Sernova Stock Forecast, Price & News

$0.92
+0.02 (+1.76%)
(As of 06/27/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.87
$0.93
50-Day Range
$0.78
$1.23
52-Week Range
$0.73
$1.76
Volume
30,016 shs
Average Volume
41,203 shs
Market Capitalization
$252.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
30 days | 90 days | 365 days | Advanced Chart

Receive SEOVF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sernova and its competitors with MarketBeat's FREE daily newsletter.

SEOVF Stock Forecast (MarketRank)

Overall MarketRank

0.96 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
Sernova logo

About Sernova (OTCMKTS:SEOVF)

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and/or hormones for the long-term treatment of various serious chronic diseases, such as diabetes, hemophilia, and thyroid disease. Sernova Corp. has a research collaboration with AgeX Therapeutics, Inc. to generate immune-protected therapeutic cells; and a research agreement with the University of Miami to advance the development of Cell Pouch cell therapy platform. The company was incorporated in 1998 and is headquartered in London, Canada.

SEOVF Stock News Headlines

IIROC Trading Resumption - SVA
Sernova Corp. (SEOVF)
See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:SEOVF
Employees
N/A
Year Founded
N/A

Company Calendar

Today
6/28/2022
Fiscal Year End
10/31/2022

Profitability

Net Income
$-5.54 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.09 per share

Miscellaneous

Free Float
N/A
Market Cap
$252.42 million
Optionable
Not Optionable
Beta
1.17














Sernova Frequently Asked Questions

How has Sernova's stock price performed in 2022?

Sernova's stock was trading at $1.45 at the beginning of 2022. Since then, SEOVF stock has decreased by 36.8% and is now trading at $0.9158.
View the best growth stocks for 2022 here
.

Who are Sernova's key executives?

Sernova's management team includes the following people:
  • Mr. Frank A. Holler MBA, Exec. Chairman (Age 65, Pay $51.51k)
  • Dr. Philip M. Toleikis B.A., M.Sc., Ph.D., Pres, CEO & Director
  • Mr. David Swetlow C.A, C.A., CPA, Chief Financial Officer
  • Mr. Douglas Maret, Chief Science Officer
  • Mr. Christopher Barnes, VP of Investor Relations

What is Sernova's stock symbol?

Sernova trades on the OTCMKTS under the ticker symbol "SEOVF."

How do I buy shares of Sernova?

Shares of SEOVF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sernova's stock price today?

One share of SEOVF stock can currently be purchased for approximately $0.92.

How much money does Sernova make?

Sernova (OTCMKTS:SEOVF) has a market capitalization of $252.42 million. The company earns $-5.54 million in net income (profit) each year or ($0.05) on an earnings per share basis.

How can I contact Sernova?

Sernova's mailing address is 700 COLLIP CIRCLE SUITE 114, LONDON A6, N6G 4X8. The official website for Sernova is www.sernova.com. The company can be reached via phone at (519) 858-5184, via email at [email protected], or via fax at 519-858-5184.

This page (OTCMKTS:SEOVF) was last updated on 6/28/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.